Important @TheLancetInfDis study by Sutanto et al doi.org/10.1016/S1473-… that led to label change for tafenoquine to not be administered with ACTs #vivax #malaria. Commentary by @KThriemer & I highlights need for further studies in different populations doi.org/10.1016/S1473-…
Rob Commons
@RobCommons
Infectious Diseases Physician | PhD Student @MenziesResearch | Global Health | Malaria
78 Following 125 Followers 11 Posts
Latest posts 4
“Malaria is very clever — it hides out where you don’t know and comes back when you aren’t ready" - candid story on the risk of drug resistant malaria in the Mekong region. @MORU @amymaxmen #malaria #malariaelimination nature.com/articles/d4158…
Major breakthrough for vivax malaria. First new drug to treat dormant liver stage and prevent relapse in 60 years. #malaria #malariaelimination
First ever FDA-approved #singledose medicine to prevent relapse of P. vivax malaria developed by MMV and @GSK, marking breakthrough in drive towards malaria eradication. https://t.co/5RasZizk0EView quoted post on X
A demonstration of how collaboration can assist in improving the tools we have to control malaria. #malaria #malariaelimination @WWARN @ricprice99 @MenziesResearch
A @WWARN @MenziesResearch IPD analysis of 5000 patients with p.vivax from 37 studies in 17 countries shows revised primaquine + chloroquine dose can lead to better result in #malaria patients https://t.co/PPH839skHr @TheLancet @ricprice99 @MORUBKK @TropMedOxford #MalariamustdieView quoted post on X